Use of mycophenolate mofetil in erythema nodosum [3]

Journal of the American Academy of Dermatology

Volumn 47, Issue 6, 2002, Pages 968-969

  Boyd, Alan S ^a  

^a VANDERBILT UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER;

ADULT; ANEMIA; ANTIBODY TITER; CASE REPORT; DRUG EFFECT; ERYTHEMA NODOSUM; FEMALE; GASTROINTESTINAL TOXICITY; GRAFT REJECTION; HUMAN; INFECTION RISK; LETTER; LEUKOPENIA; PANNICULITIS; PRIORITY JOURNAL; SKIN BIOPSY;

ADMINISTRATION, ORAL; ADULT; BIOPSY, NEEDLE; DERMATOLOGIC AGENTS; DRUG ADMINISTRATION SCHEDULE; ERYTHEMA NODOSUM; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOHISTOCHEMISTRY; MIDDLE AGED; MYCOPHENOLIC ACID; TREATMENT OUTCOME;

EID: 0036894137     PISSN: 01909622     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Letter

References (5)

1. Requena L, Sanchez Yus E. Panniculitis. Part I, J Am Acad Dermatol 2001;45:163-83.
2. Lebwohl M. Advances in psoriasis therapy. Dermatol Clin 2000; 18:13-9.
3. Lipsky J. Mycophenolate mofetil. Lancet 1996;348:1357-9.
4. Bohm M, Beissert S, Schwarz T, Metze D, Luger T. Bullous pemphigoid treated with mycophenolate mofetil [letter]. Lancet 1997; 349:541.
5. Enk AH, Knop J. Mycophenolate is effective in the treatment of pemphigus vulgaris. Arch Dermatol 1999;135:54-6.